WARCEF Sub-Study

• Research type

  Research Study

• Full title

  Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction(WARCEF)Sub-study.

• IRAS ID

  127732

• Contact name

  Gregory YH Lip

• Contact email

  g.y.h.lip@bham.ac.uk

• Sponsor organisation

  Columbia Univeristy Medical College

• Research summary

  The original WARCEF trial was conducted to determine the best treatment option between two commonly used medications Warfarin, an anticoagulant (a drug which prevents clotting), or Aspirin, a drug that reduces platelet function, in reducing stroke.

  The purpose of this Sub-study is to assess the progression of disease over time and to collect follow-up Echocardiograms and Electrocardiogram (ECGs) information, from heart failure patients who previously participated in the original WARCEF trial and subsequently underwent these procedures as part of their routine clinical care.

• REC name

  Yorkshire & The Humber - Leeds East Research Ethics Committee

• REC reference

  13/YH/0124

• Date of REC Opinion

  23 May 2013

• REC opinion

  Further Information Favourable Opinion